Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study

Translated title of the contribution: Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study

T.C. van Holten, M. Roest, J. Riphagen, C. Jansen, P. Naarding, H.J. Adriaansen, Ph.G. de Groot, J.A. Remijn

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study
Original language	Undefined/Unknown
Pages (from-to)	1177-1179
Number of pages	3
Journal	Journal of Thrombosis and Haemostasis
Volume	10
Publication status	Published - 2012

Cite this

@article{b92cce183345446ba2de34f1f94fa993,

title = "Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study",

author = "{van Holten}, T.C. and M. Roest and J. Riphagen and C. Jansen and P. Naarding and H.J. Adriaansen and {de Groot}, Ph.G. and J.A. Remijn",

year = "2012",

language = "Undefined/Unknown",

volume = "10",

pages = "1177--1179",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study

AU - van Holten, T.C.

AU - Roest, M.

AU - Riphagen, J.

AU - Jansen, C.

AU - Naarding, P.

AU - Adriaansen, H.J.

AU - de Groot, Ph.G.

AU - Remijn, J.A.

PY - 2012

Y1 - 2012

M3 - Article

SN - 1538-7933

VL - 10

SP - 1177

EP - 1179

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

ER -